E Thehiloe ka 2009, JYMed ke mofani oa litšebeletso tse ka sehloohong tsa peptide CRDMO le moetsi oa API ea generic naheng ea China e sebetsanang le tloaelo ea ho kopanya, nts'etsopele ea ts'ebetso, phepelo ea bongaka le thekiso ea lintho tsa peptide. Khamphani e sebelisa li-FTEs tse ka bang 600+, tse nang le sehlopha sa batsamaisi ba mantlha se entsoeng ka litsebi tse nang le boiphihlelo ba lilemo tse fetang 20 tsa theknoloji ea peptide. JYMed e sebetsa setsi se le seng sa R&D le lits'ebeletso tse peli tse kholo tsa tlhahiso ea merero e mengata, tse nang le matla a tlhahiso ea lithane tse ngata tsa peptide.

MABAPI LE
JYMED

JYMed ke moetsi oa lipeptide o hlahlobiloeng ke FDA oa US ea sebetsanang le li-peptide tsa litlolo, li-API tsa li-peptide le li-peptide tsa tloaelo. Lihlahisoa tsa rona tse hlahang li kenyelletsa Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-Cu, Acetyl Hexapeptide-8, le ho feta. Ho ithuta haholoanyane, ka kopo ikopanye le rona ho:

Email: jymed@jymedtech.com

litaba le tlhahisoleseding

.